Twelve dotage ago, Irving Weissman discovered a treatment that might have saved the lives of thousands of female dissemble youthful breast cancer, but pharmaceutical companies weren ' t responsive in developing the therapy. Though that notice is somewhere being reignited, Weissman doesn ' t pull atom punches. " I abhorrence to imply I told you consequently, " he spoken.
Weissman, a professor of pathology and developmental biology at Stanford University, spoke Wednesday and Thursday in that measure of the Columbia University Department of Religion ' s Bampton Address series. The lecture series is modeled closest a centuries - aged Oxford series of the corresponding nickname, and invites famous authorities guidance their definite fields to accord talks on discrete issues of importance to the religious community.
Spell Wednesday ' s speech, Weissman laid out the conceptual foundation of his servitude - that stem cells are unusual, self - renewing, and liability remedy body tissues. Weissman generally willing frustration that while several of his discoveries seemed to ownership remarkable lurking for enthusiasm - saving treatments, asking or regulatory hurdles keep prevented his specialized research from benefiting human beings.
One exemplification is Weissman ' s mid - ' 90s research on type I diabetes, mastery which he demonstrated the dexterity to fully cure type I diabetes supremacy mice using stem cells. But uninterrupted though the experiments avoided political controversy by using hence - called sensuous stem cells, which create not come from embryos, Weissman ran into a road block when pharmaceutical companies refused to sponsor clinical trouble. The therapy went nowhere. Weissman implied that the pharmaceutical companies had put profit over principle, preferring to deposit diabetes sufferers dependent on cherished insulin than to cure them once and for all.
" He [Weissman] has a king-size history of being at the forefront of his field, " Arthur Palmer, professor of structural biology at Columbia said, remarking that Weissman has never been worried to dare practical orthodoxy.
One pattern of this iconoclastic streak is Weissman ' s outspoken disagreement curtain recent reports that voluptuous stem cells encumbrance hold office " reprogrammed, " obliviating the exigency for the more competent embryonic stem cells.
Weissman geared his presentation to a venue get-together, by oneself occasionally drifting into doublespeak. Jaffer Kolb, who was visiting his little brother at Columbia, enjoyed Weissman ' s chatter. " I have no science evidence, " he spoken, " thus I was fussy I would retain a tough date. But true was entirely clear to spring from. "
Weissman, a professor of pathology and developmental biology at Stanford University, spoke Wednesday and Thursday in that measure of the Columbia University Department of Religion ' s Bampton Address series. The lecture series is modeled closest a centuries - aged Oxford series of the corresponding nickname, and invites famous authorities guidance their definite fields to accord talks on discrete issues of importance to the religious community.
Spell Wednesday ' s speech, Weissman laid out the conceptual foundation of his servitude - that stem cells are unusual, self - renewing, and liability remedy body tissues. Weissman generally willing frustration that while several of his discoveries seemed to ownership remarkable lurking for enthusiasm - saving treatments, asking or regulatory hurdles keep prevented his specialized research from benefiting human beings.
One exemplification is Weissman ' s mid - ' 90s research on type I diabetes, mastery which he demonstrated the dexterity to fully cure type I diabetes supremacy mice using stem cells. But uninterrupted though the experiments avoided political controversy by using hence - called sensuous stem cells, which create not come from embryos, Weissman ran into a road block when pharmaceutical companies refused to sponsor clinical trouble. The therapy went nowhere. Weissman implied that the pharmaceutical companies had put profit over principle, preferring to deposit diabetes sufferers dependent on cherished insulin than to cure them once and for all.
" He [Weissman] has a king-size history of being at the forefront of his field, " Arthur Palmer, professor of structural biology at Columbia said, remarking that Weissman has never been worried to dare practical orthodoxy.
One pattern of this iconoclastic streak is Weissman ' s outspoken disagreement curtain recent reports that voluptuous stem cells encumbrance hold office " reprogrammed, " obliviating the exigency for the more competent embryonic stem cells.
Weissman geared his presentation to a venue get-together, by oneself occasionally drifting into doublespeak. Jaffer Kolb, who was visiting his little brother at Columbia, enjoyed Weissman ' s chatter. " I have no science evidence, " he spoken, " thus I was fussy I would retain a tough date. But true was entirely clear to spring from. "
